Sarepta Therapeutics, Inc.
USD17.02
+0.17 (+1.01%)
CEO
Douglas S. Ingram
IPO Date
1997-06-04
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$16.89
Prev. Close
$16.85
Day Low
$16.44
Day High
$17.40
52W Low
$10.42
52W High
$25.32
Market Cap
$1.80B
Volume
3.74M
| 16,875 |
| $0.00 |
| 5 Jun 2026 | Wigzell Hans Lennart Rudolf | director | A-Award | Acquired | 16,875 | $0.00 |
| 5 Jun 2026 | BEHRENS M KATHLEEN | director | A-Award | Acquired | 16,875 | $0.00 |
| 5 Jun 2026 | Connelly Deirdre P | director | A-Award | Acquired | 16,875 | $0.00 |
| 5 Jun 2026 | Nicaise Claude | director | A-Award | Acquired | 16,875 | $0.00 |
| 5 Jun 2026 | Chambers Michael Andrew | director | A-Award | Acquired | 16,875 | $0.00 |
| 5 Jun 2026 | Barry Richard | director | A-Award | Acquired | 16,875 | $0.00 |
| 13 Mar 2026 | Estepan Ian Michael | Chief Operating Officer | F-InKind | Disposed | 1,097 | $17.03 |
| 13 Mar 2026 | Wong Ryan Ho-Yan | Chief Financial Officer | F-InKind | Disposed | 256 | $17.03 |
| $15,001 - $50,000 |
| 20 Apr 2023 | Josh Gottheimer | Josh Gottheimer | Purchase | $1,001 - $15,000 |
| 17 Apr 2023 | Daniel Goldman | Daniel Goldman | Purchase | $15,001 - $50,000 |
| 24 Feb 2023 | Daniel Goldman | Daniel Goldman | Sale | $1,001 - $15,000 |
| 9 Dec 2020 | Josh Gottheimer | Josh Gottheimer | Sale (Full) | $1,001 - $15,000 |
| 14 Oct 2020 | Gilbert Cisneros | Gilbert Cisneros | Purchase | $1,001 - $15,000 |
| 17 Jul 2020 | Gilbert Cisneros | Gilbert Cisneros | Sale (Partial) | $1,001 - $15,000 |
| 6 Jan 2020 | Josh Gottheimer | Josh Gottheimer | Purchase | $1,001 - $15,000 |